We Avoid RAAS Inhibitors in PD Patients with Residual Renal Function

Preserving residual renal function in patients on peritoneal dialysis (PD) positively impacts mortality. While it is important to avoid nephrotoxic agents in this setting, clinicians should appreciate that inhibitors of the renin‐angiotensin‐aldosterone system (RAAS), including angiotensin convertin...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Seminars in dialysis 2016-07, Vol.29 (4), p.265-267
1. Verfasser:	Turner, Jeffrey M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiotensin Receptor Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Glomerular Filtration Rate Humans Kidney Failure, Chronic - therapy Nephrology - methods Peritoneal Dialysis Renin-Angiotensin System
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!